Home / Knowledge / News / Textiles / Ube to stop caprolactam production at Sakai plant
Ube to stop caprolactam production at Sakai plant
19
Feb '13
Ube Industries, Ltd. announced that it will cease production of caprolactam (CPL) at the Sakai Factory in Japan. The decision was made at a meeting of the Board of Directors and will result in the company recording an extraordinary loss for the fiscal year ending March 31, 2013. Details of the decision are described below.

Reason for Ceasing Production

Ube began manufacturing and marketing caprolactam in 1955, supplying raw material caprolactam for nylon, which is widely, used in fiber and plastics applications. The caprolactam business grew on the strength of Ube’s reputation for quality and reliable supply, over time growing to encompass a global supply framework with four plants situated in Ube and Sakai in Japan, and in Spain and Thailand respectively.

However, with the global economic slowdown starting in 2012, growth in demand for caprolactam has weakened while market conditions for caprolactam have been heavily eroded by the entry of new manufacturers and successive production expansion of existing manufacturers centering on Chinese companies,. At the same time, prices for raw material benzene and auxiliary materials have risen, with the net effect that the profitability of the caprolactam business has rapidly declined.

Among Ube’s four manufacturing facilities, the caprolactam facilities at the Sakai Factory are the least competitive, due to high manufacturing costs based on the production techniques employed and facilities for auxiliary materials and steam utilities that are dependent on liquefied natural gas (LNG) for fuel. As a result, Ube put extra effort into examining and implementing various measures to improve profitability at the plant.

However, these measures are not enough to overcome the recent changes in business conditions, and the prospects for improving the profitability of caprolactam production at the Sakai Factory are dim. Therefore, Ube has made the decision that it is in its best interests to cease caprolactam production at the Sakai Factory after a fixed period of time and dismantle the facilities, in order to strengthen the overall competitiveness of the caprolactam business.

Ube will also cease production of related derivative products at the Sakai Factory and dismantle those facilities. Thereafter, Ube will designate Sakai Factory mainly for value-added specialty products including lithium-ion battery materials, in order to strengthen the Factory.

Ube will continue to supply customers with the affected products from its other manufacturing facilities, endeavoring to make the transition as smooth as possible for customers to secure their supply for another manufacturer. Employees who are currently engaged in caprolactam production at the Sakai Factory will be shifted to production for specialty products including separators for lithium-ion batteries, whose production is set to be expanded at the Sakai Factory.

Must ReadView All

Textiles | On 28th Mar 2017

India may impose duty on elastomeric filament yarn

The Government of India is likely to impose anti-dumping duty on...

Courtesy: Kraig Laboratories

Textiles | On 28th Mar 2017

Kraig gets certificate for silk production in Vietnam

Kraig Biocraft Laboratories, Inc., a leading biotechnology company...

Information Technology | On 28th Mar 2017

Intex Consulting signs partnership with Kawan Era Baru

Germany based Intex Consulting GmbH has entered into a strategic...

Interviews View All

C Kamatchisundaram
Voltas

ITME is an occasion not only to receive new leads but also to work on...

Angelina Francesca Cheang
MY ANJE

'Consumers in the age-group 21 to 38 are driving the activewear trend'

Jim Desai
Blaiva Fabricaa

Fashion industry likely to remain labour-intensive in coming years

Kai Poehler
Voith Paper GmbH & Co. KG

The glass mat industry is growing by five to eight per cent annually. Kai...

Giorgio Mantovani
Corman S.p.A

Giorgio Mantovani, MD of Corman, with a presence in both Milano and New...

Mohammad Hassan
Biax Fiberfilm

About one in every 20 patients picks up an infection while hospitalised....

Yash P. Kotak
Bombay Hemp Company

One of the directors of Bombay Hemp Company, Yash P. Kotak, speaks to...

Sanjukta Dutta
Sanjukta's Studio

<b>Sanjukta Dutta</b> creates unique garments by clubbing prints of...

Jay Ramrakhiani
Occasions Elegance Wear

It is believed that by early 19th century, Varanasi weavers had moved away ...

Press Release

Press Release

Letter to Editor

Letter to Editor

RSS Feed

RSS Feed

Submit your press release on


editorial@fibre2fashion.com

Letter To Editor






(Max. 8000 char.)

Search Companies





SEARCH
March 2017

March 2017

Subscribe today and get the latest update on Textiles, Fashion, Apparel and so on.

SUBSCRIBE


Browse Our Archives

GO


eNEWS
Insights
Subscribe today and get the latest News update in your mail box.
Advanced Search